{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:13:19Z","timestamp":1788459199799,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cbi.2019.108914","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T05:47:25Z","timestamp":1576475245000},"page":"108914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin"],"prefix":"10.1016","volume":"316","author":[{"given":"Yuli","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara K.","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.108914_bib1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM198405103101902","article-title":"The pharmacokinetics of heroin in patients with chronic pain","volume":"310","author":"Inturrisi","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2019.108914_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1067\/mcp.2001.117981","article-title":"Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics","volume":"70","author":"Rentsch","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0009-9236(03)00199-1","article-title":"Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts","volume":"74","author":"Girardin","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157488406775268219","article-title":"Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature","volume":"1","author":"Rook","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2019.108914_bib5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0024-3205(83)90616-1","article-title":"Evidence from opiate binding studies that heroin acts through its metabolites","volume":"33","author":"Inturrisi","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2019.108914_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0006-2952(01)00689-X","article-title":"Mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine","volume":"62","author":"Selley","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108914_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.109.152462","article-title":"Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo","volume":"331","author":"Andersen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5414\/CPP38486","article-title":"Pharmacodynamics and pharmacokinetics of intravenously, orally and rectally administered diacetylmorphine in opioid dependents, a two-patient pilot study within a heroin-assisted treatment program","volume":"38","author":"Gyr","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.178.4064.984","article-title":"Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection","volume":"178","author":"Oldendorf","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.cbi.2019.108914_bib10","article-title":"The role of 6-acetylmorphine in heroin-induced reward and locomotor sensitization in mice","author":"Kvello","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.cbi.2019.108914_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)32246-9","article-title":"Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase","volume":"215","author":"Lockridge","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)21180-6","article-title":"Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases","volume":"279","author":"Kamendulis","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib13","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1111\/j.1476-5381.2010.00700.x","article-title":"Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin","volume":"160","author":"Hatfield","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108914_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9673(00)91213-5","article-title":"Kinetics of heroin deacetylation in aqueous alkaline solution and in human serum and whole blood","volume":"110","author":"Nakamura","year":"1975","journal-title":"J Chromatogr"},{"key":"10.1016\/j.cbi.2019.108914_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1440-1681.1999.03090.x","article-title":"Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine","volume":"26","author":"Salmon","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.cbi.2019.108914_bib16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","article-title":"Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine","volume":"34","author":"Imai","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2019.108914_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jbt.20178","article-title":"Human carboxylesterases and their role in xenobiotic and endobiotic metabolism","volume":"21","author":"Ross","year":"2007","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.cbi.2019.108914_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jat\/18.6.317","article-title":"Pharmacokinetics and pharmacodynamics of smoked heroin","volume":"18","author":"Jenkins","year":"1994","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cbi.2019.108914_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2006.pto_233.x","article-title":"Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients","volume":"98","author":"Rook","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.cbi.2019.108914_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cbi.2019.108914_bib21","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2019.108914_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/dmd.118.086074","article-title":"In vitro inhibition of carboxylesterase 1 by major cannabinoids and selected metabolites","volume":"47","author":"Qian","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2019.108914_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0041-008X(86)90432-1","article-title":"Alteration of in vivo and in vitro effects of heroin by esterase inhibition","volume":"82","author":"Gianutsos","year":"1986","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108914_bib24","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ajhg.2008.04.015","article-title":"Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis","volume":"82","author":"Zhu","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2019.108914_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0021-9673(01)95317-8","article-title":"Simple high-performance liquid chromatographic method for the separation of 3,6-diacetylmorphine hydrochloride (heroin) and hydrolysis products","volume":"171","author":"Poochikian","year":"1979","journal-title":"J Chromatogr"},{"key":"10.1016\/j.cbi.2019.108914_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0378-5173(83)90008-X","article-title":"Heroin: stability and formulation approaches","volume":"13","author":"Poochikian","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2019.108914_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0163-7258(99)00028-5","article-title":"The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future","volume":"84","author":"Crespi","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-3565(24)29543-4","article-title":"Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate","volume":"297","author":"Venkatakrishnan","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib29","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/jpet.106.111807","article-title":"Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel","volume":"319","author":"Shi","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.108914_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40262-014-0226-2","article-title":"Effects of alcohol on human carboxylesterase drug metabolism","volume":"54","author":"Parker","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cbi.2019.108914_bib31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.xphs.2018.09.022","article-title":"Contribution of human liver and intestinal carboxylesterases to the hydrolysis of selexipag in vitro","volume":"108","author":"Imai","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2019.108914_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/187231211798472511","article-title":"Investigation of the metabolism of rufinamide and its interaction with valproate","volume":"5","author":"Williams","year":"2011","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.cbi.2019.108914_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cbi.2019.108914_bib34","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1373\/clinchem.2016.263475","article-title":"Free and glucuronide whole blood cannabinoids' pharmacokinetics after controlled smoked, vaporized, and oral cannabis administration in frequent and occasional cannabis users: identification of recent cannabis intake","volume":"62","author":"Newmeyer","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cbi.2019.108914_bib35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.cbi.2019.108914_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/phar.1194","article-title":"The role of human carboxylesterases in drug metabolism: have we overlooked their importance?","volume":"33","author":"Laizure","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cbi.2019.108914_bib37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jps.2600630705","article-title":"Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol","volume":"63","author":"Garrett","year":"1974","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2019.108914_bib38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/dmd.119.086470","article-title":"Quantifying hepatic enzyme kinetics of (-)-(9)-Tetrahydrocannabinol (THC) and its psychoactive metabolite, 11-OH-THC, through in vitro modeling","volume":"47","author":"Patilea-Vrana","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2019.108914_bib39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13311-015-0373-7","article-title":"Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage","volume":"12","author":"Hurd","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.cbi.2019.108914_bib40","first-page":"33","article-title":"Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence","volume":"9","author":"Prud'homme","year":"2015","journal-title":"Subst. Abus."},{"key":"10.1016\/j.cbi.2019.108914_bib41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/JCP.0000000000001089","article-title":"The potential for pharmacokinetic interactions between cannabis products and conventional medications","volume":"39","author":"Qian","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cbi.2019.108914_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.ftd.0000211812.27558.6e","article-title":"Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine","volume":"28","author":"Maurer","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cbi.2019.108914_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bcp.2018.01.028","article-title":"Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung","volume":"150","author":"Gabriele","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108914_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","article-title":"Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes","volume":"89","author":"Jiang","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2019.108914_bib45","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/dmd.114.056994","article-title":"Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase","volume":"42","author":"Shimizu","year":"2014","journal-title":"Drug Metab. Dispos."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719317259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719317259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:20:21Z","timestamp":1788456021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719317259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":45,"alternative-id":["S0009279719317259"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108914","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108914"}}